Life Science News

RSS

Newly identified enzyme protects growth protein in leukemia cells

A research team has identified an enzyme that helps acute myeloid leukemia (AML) cells survive by protecting c-MYC, a protein that drives cell growth, from degradation.

13 Nov 2026

Broad genomic sequencing extends survival in advanced lung cancer patients

New research in the November 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that patients with advanced non-small cell lung cancer (NSCLC) lived longer when they received broad-based genomic sequencing (BGS)-testing a large panel of dozens or hundreds of genes at once-before starting treatment, compared with patients who received more limited biomarker testing of just one or two genes.

13 Nov 2026

Sino Biological advances AI-designed molecule validation with 4RISE™

AI can generate protein candidates at an unprecedented speed, but experimental validation remains essential to determine whether they properly express, bind targets, and demonstrate the desired biological properties.

From Sino Biological Inc. 13 Nov 2026

Scientists unveil first comprehensive atlas of basal ganglia cell types

Capturing a complete picture of what causes brain diseases from schizophrenia and Parkinson's disease to addiction has long remained a challenge to scientists.

12 Nov 2026

Human heart tissue model offers insights into inherited cardiomyopathy

Inherited cardiomyopathies - diseases of the heart muscle, which cause the heart to have a harder time pumping blood to the rest of the body - are the leading cause of heart failure in young adults.

12 Nov 2026

Your fitness may say less about cellular aging than you think

In a study of 84 middle-aged adults, researchers found that higher perceived stress and older age were associated with shorter telomeres, while physical fitness, body composition, and lifestyle habits showed no consistent independent associations. The findings suggest that telomere length may reflect psychosocial and health-related burden more closely than current physical performance, although the reported chronic disease association requires clarification because of an inconsistency in the paper's statistical coding.

12 Nov 2026

New light-based tool reveals how cells regulate autophagy

Inside each cell is a dynamic world of molecules and chemicals, signals and receivers, and construction and destruction.

12 Nov 2026

Liver-derived protein helps protect brain cells and improves memory in Alzheimer's mice

Researchers identified 92 circulating proteins that cross the blood-brain barrier and enter brain tissue, revealing how proteins such as liver-derived APOA1 help regulate astrocyte cholesterol metabolism and support neuronal synapses. In an Alzheimer's disease mouse model, APOA1 transport was impaired, but increasing its production in the liver reduced selected inflammatory and amyloid-related abnormalities, improved synaptic integrity, and enhanced some measures of memory.

12 Nov 2026

New method reveals how individual glioblastoma cells spread through the brain

By combining live imaging of brain tissue with artificial intelligence, researchers at Uppsala University have developed a method that reveals how individual glioblastoma cells spread through the brain, how they can switch between different ways of moving, and how they are affected by cancer treatments. An

12 Nov 2026

Researchers identify previously unknown cause of fatal newborn brain disorder

Researchers at King Abdullah University of Science and Technology (KAUST) and King Faisal Specialist Hospital and Research Center (KFSHRC) identify a previously unknown cause of a fatal newborn brain disorder, giving long-awaited answers to families whose children were affected by the disease.

11 Nov 2026

T-Cypher Bio extends footprint in purpose-built laboratory space at Abingdon Science Park, Oxford

T-Cypher Bio ("T-Cypher), a biotechnology company developing novel T cell receptor (TCR)-based T cell engagers that target high copy number antigens, today announced its relocation to Abingdon Science Park, Oxford, UK.

11 Nov 2026

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026.

From Mogrify 11 Nov 2026

L.B. Bohle will be showcasing productive, energy-efficient and scalable OSD solutions at PMEC India 2026

The challenge for India’s pharmaceutical manufacturers is clear: How to reliably scale production, reduce energy costs, and safeguard operators – all at once. From November 24 to 26, 2026, L.B. Bohle will present these solutions at stand 9C02 in the India Expo Centre & Mart (IEML) in Greater Noida.

From L.B. Bohle Maschinen und Verfahren GmbH 11 Nov 2026

Study proposes overlooked genetic mechanism behind schizophrenia and bipolar disorder

Schizophrenia and bipolar disorder run in families with a stubbornness that twin studies put at 81 percent heritability.

10 Nov 2026

Qureight’s fibrosis imaging biomarker selected by Contineum Therapeutics as a secondary endpoint in Phase 2 PROPEL-IPF clinical trial

Qureight, an end-to-end imaging company providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, and Contineum Therapeutics, Inc. (Contineum), a clinical-stage biopharmaceutical company pioneering differentiated small molecule therapies for inflammatory and fibrotic diseases with significant unmet need, today announced that Qureight’s Fibr8™ quantitative imaging biomarker is being used as a secondary endpoint in Contineum’s PROPEL-IPF Phase 2 clinical trial examining the safety and efficacy of PIPE-791, Contineum’s lead drug candidate, in idiopathic pulmonary fibrosis (IPF) patients.

10 Nov 2026

The Critical Role of Sample Storage in Drug Discovery and Development

Astoriom's CEO, Will Edwards, highlights the importance of biological sample management and storage stability in advancing drug discovery and development.

10 Nov 2026

No need to rewrite Darwin’s theory of evolution, study finds

The largest analysis of its kind finds no evidence that important genes are protected from mutation, challenging claims that our established understanding of evolution needs to be rewritten.

10 Nov 2026

Phage protein study opens new path for future antibiotics

Drug-resistant bacteria are becoming more common worldwide, posing a major public health challenge. Addressing this problem requires finding new ways to eliminate bacteria, which in turn requires analyzing essential cellular processes that could serve as targets for future antibiotics.

9 Nov 2026

Histone subvariant H3mm15 plays key role in sperm development

Researchers from Kyushu University have found that H3mm15, a histone H3.3 subvariant, contributes to normal sperm development in mice by helping regulate gene expression during spermatogenesis.

8 Nov 2026

AI tool uncovers hidden interactions among human mitochondrial proteins

Artificial intelligence is helping Texas A&M AgriLife Research scientists fast-track answers to a long-standing question in human biology: What do hundreds of mystery proteins in the mitochondria actually do?

6 Nov 2026